Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

XAIR - Beyond Air, Inc.


IEX Last Trade
0.4056
0   0%

Share volume: 312,220
Last Updated: Mon 23 Dec 2024 04:41:06 PM CET
Surgical and Medical Instrument Manufacturing : 0.38%

PREVIOUS CLOSE
CHG
CHG%

$0.41
0.02
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
29%
Profitability 33%
Dept financing 19%
Liquidity 40%
Performance 25%
Company vs Stock growth
vs
Performance
5 Days
-6.34%
1 Month
-26.17%
3 Months
7.29%
6 Months
-69.92%
1 Year
-81.08%
2 Year
-93.54%
Key data
Stock price
$0.41
P/E Ratio 
0.00
DAY RANGE
$0.41 - $0.43
EPS 
$0.00
52 WEEK RANGE
$0.34 - $2.36
52 WEEK CHANGE
-$81.08
MARKET CAP 
20.562 M
YIELD 
N/A
SHARES OUTSTANDING 
46.521 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
1.01
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$564,295
AVERAGE 30 VOLUME 
$804,486
Company detail
CEO: Steven A. Lisi
Region: US
Website: beyondair.net
Employees: 70
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Beyond Air, Inc. develops nitric oxide generator and delivery systems. LungFit system is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors.

Recent news